MDS Task Force and Committee Papers

These papers represent the work of various MDS Task Forces, Committees, and Study Groups to address areas in the field of Movement Disorders. Their results and efforts further the clinical and scientific mission of the Society. They include position papers, critiques and recommendations on rating scales, guidelines, and reports.

Dystonia and Dyskinesias

Missing data in the Unified Dyskinesia Rating Scale (UDysRS)
September-October 2018
Luo S, Ren X, Han W, Goetz CG, Stebbins GT
Movement Disorders Clinical Practice, 5(5): 523-526
*A publication of the MDS Rating Scales Program

Dystonia rating scales: Critique and recommendations
(June 2013)
Albanese A, Del Sorbo F, Comella C, Jinnah HA, Mink JW, Post B, Vidailhet M, Volkmann J, Warner TT, Leentjens AFG, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A
Movement Disorders, 28(7): 874-883
* A publication of the MDS Committee on Rating Scales in Movement Disorders (previously the MDS Task Force on Rating Scales for Parkinson’s Disease)

Task force report on scales to assess dyskinesia in Parkinson’s disease: Critique and recommendations
(July 2010)
Colosimo C, Martinez-Martin P, Fabbrini G, Hauser RA, Merello M, Miyasaki J, Poewe W, Sampaio C, Rascol O, Stebbins GT, Schrag A, Goetz CG
Movement Disorders, 25(9):1131-1142
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease and the MDS Dyskinesia Rating Scales Task Force

Functional Neurological Disorders

Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders
September 2018
Espay AJ, Aybek S, Carson A, Edwards MJ, Goldstein LH, Hallett M, LaFaver K, LaFrance WC, Lang AE, Nicholson T, Nielsen G, Reuber M, Voon V, Stone J, Morgante F
JAMA Neurology, 75(9): 1132-1114
*A publication of the MDS Functional Movement Disorders Study Group

Genetic Classification of Movement Disorders

The genetic nomenclature of recessive cerebellar ataxias
(July 2018)
Rossi M, Anheim M, Durr A, Klein C, Koenig M, Synofzik M, Marras C, van de Warrenburg BP
Movement Disorders, 33 (7): 1056-1076
*A publication of the MDS Task Force on Classification and Nomenclature of Genetic Movement Disorders

Genotype‐phenotype relations for the Parkinson's disease genes Parkin, PINK1, DJ1: MDSGene systematic review
(May 2018)
Kasten M, Hartmann C, Hampf J, Schaake S, Westenberger A, Vollstedt E, Balck A, Domingo A, Vulinovic F, Dulovic M, Zorn I, Madoev H, Zehnle H, Lembeck CM, Schawe L, Reginold J, Huang J, König IR, Bertram L, Marras C, Lohmann K, Lill CM, Klein C
Movement Disorders, 33(5):730-741
*A publication of the MDS Task Force on Classification and Nomenclature of Genetic Movement Disorders

Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force
(April 2016)
Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek‐Mahmutoglu S, Ebrahimi‐Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C
Movement Disorders, 31(4):436-457
*A publication of the MDS Task Force on Classification and Nomenclature of Genetic Movement Disorders

Huntington's Disease

Rating scales and performance‐based measures for assessment of functional ability in Huntington's disease: Critique and recommendations
(July-August 2018)
Mestre TA, Busse M, Davis AM, Quinn L, Rodrigues FB, Burgunder JM, Carlozzi NE, Walker F, Ho AK, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT
Movement Disorders Clinical Practice, 5(4): 361-372
*A publication of the MDS Subcommittee on Review of Huntington's Disease Rating Scales

Quality of life in Huntington's disease: Critique and recommendations for measures assessing patient health‐related quality of life and caregiver quality of life
(May 2018)
Mestre TA, Carlozzi NE, Ho AK, Burgunder JM, Walker F, Davis AM, Busse M, Quinn L, Rodrigues FB, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT
Movement Disorders, 2018 May;33(5):742-749
*A publication of the MDS Subcommittee on Review of Huntington's Disease Rating Scales

Rating scales for motor symptoms and signs in Huntington's disease: Critique and recommendations
(March 2018)
Mestre TA, Forjaz MJ, Mahlknecht P, Cardoso F, Ferreira JJ, Reilmann R, Sampaio C, Goetz CG, Cubo E, Martinez‐Martin P, Stebbins GT
Movement Disorders Clinical Practice, 5(2):111-117
*A publication of the MDS Subcommittee on Review of Huntington's Disease Rating Scales

Rating scales for cognition in Huntington's disease: Critique and recommendations
(Feb 2018)
Mestre TA, Bachoud-Lévi AC, Marinus J, Stout JC, Paulsen JS, Como P, Duff K, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P
Movement Disorders, 33(2):187-195
*A publication of the MDS Subcommittee on Review of Huntington's Disease Rating Scales

Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations
(Oct 2016)
Mestre TA, van Duijn E, Davis AM, Bachoud-Lévi AC, Busse M, Anderson KE, Ferreira JJ, Mahlknecht P, Tumas V, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P
Movement Disorders, 31(10):1466-1478
*A publication of the MDS Subcommittee on Review of Huntington's Disease Rating Scales

Diagnostic criteria for Huntington’s disease based on natural history
(Sept 2014)
Reilmann R, Leavitt BR, Ross CA
Movement Disorders, 29(11):1335-1341
*A publication of the MDS Task Force on Huntington’s Disease

Huntington's disease: Natural history, biomarkers and prospects for therapeutics
(April 2014)
Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ
Nature Reviews Neurology, 10(4):204-216
*A publication of the MDS Task Force on Huntington’s Disease

MDS Unified Parkinson’s Disease Rating Scale

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
(Nov 2008)
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez‐Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N
Movement Disorders, 23(15):2129-2170
*A publication of the MDS Task Force on Developing the MDS-UPDRS

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format and clinimetric testing plan
(Jan 2007)
Goetz CG, Fahn S, Martinez‐Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N
Movement Disorders, 22(1):41-47
*A publication of the MDS Task Force on Developing the MDS-UPDRS

The Unified Parkinson’s Disease Rating Scale (UPDRS): Status and recommendations
(July 2003)
The Movement Disorder Society Task Force on ratings scales for Parkinson’s disease
Movement Disorders, 18(7):738-750
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease

Parkinson's Disease

Risk of Parkinson's disease dementia related to level I MDS PD‐MCI
(online January 2019)
Hoogland J, Boel JA, de Bie RM, Schmand BA, Geskus RB, Dalrymple‐Alford JC, Marras C, Adler CH, Weintraub D, Junque C, Pedersen KF, Mollenhauer B, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ
Movement Disorders, (print publication pending)
*A publication of the MDS Study Group on Validation of Mild Cognitive Impairment in Parkinson’s Disease (PD-MCI)

Detecting mild cognitive deficits in Parkinson's disease: Comparison of neuropsychological tests
(November 2018)
Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple‐Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu R, Klein M, Rodriguez‐Oroz MC, Cammisuli DM, Barone P, Biundo R, de Bie RM, Schmand BA, Tröster AI, Burn DJ, Litvan I, Filoteo JV, Geurtsen GJ, Weintraub D
Movement Disorders, 33(11): 1750-1759
*A publication of the MDS Study Group on Validation of Mild Cognitive Impairment in Parkinson’s Disease (PD-MCI)

Imaging markers of progression in Parkinson's disease
(November 2018)
Strafella AP, Bohnen NI, Pavese N, Vaillancourt DE, van Eimeren T, Politis M, Tessitore A, Ghadery C, Lewis S
Movement Disorders Clinical Practice, 5(6): 586-596
*A publication of the MDS Neuroimaging Study Group

Merging clinical and imaging biomarkers to tackle Parkinson's disease
(Sept 2017)
Picillo M, Barone P, Pellecchia MT
Movement Disorders Clinical Practice, 4(5): 652-662
*A publication of the MDS Task Force on the Definition of PD

Mild cognitive impairment as a risk factor for Parkinson's disease dementia
(July 2017)
Hoogland J, Boel JA, de Bie RM, Geskus RB, Schmand BA, Dalrymple‐Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ
Movement Disorders, 32(7): 1056-1065
*A publication of the MDS Study Group on Validation of Mild Cognitive Impairment in Parkinson’s Disease (PD-MCI)

Disability rating scales in Parkinson's disease: Critique and recommendations
(Oct 2016)
Shulman LM, Armstrong M, Ellis T, Gruber-Baldini A, Horak F, Nieuwboer A, Parashos S, Post B, Rogers M, Siderowf A, Goetz CG, Schrag A, Stebbins GT, Martinez-Martin P
Movement Disorders, 31(10):1455-1468
*A publication of the MDS Committee on Rating Scales Development

Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations
(Sept 2016)
Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B, Ruzicka E, Goetz C, Stebbins G, Martinez-Martin P, Schrag A
Movement Disorders, 31(9):1342-1355
*A publication of the MDS Committee on Rating Scales Development and the MDS Disability Rating Scales Review Task Force

Technology in Parkinson's disease: Challenges and opportunities
(Sept 2016)
Espay AJ, Bonato P, Nahab FB, Maetzler W, Dean JM, Klucken J, Eskofier BM, Merola A, Horak F, Lang AE, Reilmann R, Giuffrida J, Nieuwboer A, Horne M, Little MA, Litvan I, Simuni T, Dorsey ER, Burack MA, Kubota K, Kamondi A, Godinho C, Daneault JF, Mitsi F, Krinke L, Hausdorff JM, Bloem BR, Papapetropoulos S
Movement Disorders, 31(9):1272-1282
*A publication of the MDS Task Force on Technology

MDS clinical diagnostic criteria for Parkinson's disease
(Oct 2015)
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G
Movement Disorders, 30(12):1591-1601.
*A publication of the MDS Task Force on the Definition of Parkinson’s Disease

MDS research criteria for prodromal Parkinson's disease
(Oct 2015)
Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G
Movement Disorders, 30(12): 1600-1611
*A publication of the MDS Task Force on the Definition of Parkinson’s Disease

Diagnosing PD‐MCI by MDS task force criteria: How many and which neuropsychological tests?
(March 2015)
Goldman JG, Holden S, Ouyang B, Bernard B, Goetz CG, Stebbins GT
Movement Disorders, 30(3):402-406
*A publication of the MDS Task Force on PD‐MCI

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
(April 2014)
Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G
Movement Disorders, 29(4):454-462
*A publication of the MDS Task Force on the Definition of Parkinson’s Disease

Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease
(Feb 2014)
Dodel R, Jönsson B, Reese JP, Winter Y, Martinez-Martin P, Holloway R, Sampaio C, Růžička E, Hawthorne G, Oertel W, Poewe W, Stebbins G, Rascol O, Goetz CG, Schrag A
Movement Disorders, 29(2):169-176
*A publication of the MDS Committee on Rating Scales Development

Parkinson's disease mild cognitive impairment: Application and validation of the criteria
(Jan 2014)
Geurtsen GJ, Hoogland J, Goldman JG, Schmand BA, Tröster AI, Burn DJ, Litvan I.
Journal of Parkinson's Disease, 4(2):131-137
*A publication of the MDS Study Group on the Validation of the PD-MCI Criteria

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society task force guidelines
(March 2012)
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams‐Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M
Movement Disorders, 27(3):349-356
*A publication of the MDS Task Force on the Definition of PD-MCI

Health-related quality-of-life scales in Parkinson’s disease: Critique and recommendations
(Nov 2011)
Martinez-Martin P, Jeukens-Visser M, Lyons KE, Rodriguez-Blazquez C, Selai C, Siderowf A, Welsh M, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG, Schrag A
Movement Disorders, 26(13):2371-2380
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease

Wearing-off scales in Parkinson’s disease: Critique and recommendations
(Oct 2011)
Antonini A, Martinez-Martin P, Chauduri RK, Merello M, Hauser R, Katzenschlager R, Odin P, Stacy M, Stocchi F, Poewe W, Rascol O, Sampaio C, Schrag A, Stebbins GT, Goetz CG
Movement Disorders, 26(12):2169-2175
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease

Diagnostic procedures for Parkinson's disease dementia: Recommendations from the Movement Disorder Society task force
(Dec 2007)
Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M
Movement Disorders, 22(16):2314-2324
*A publication of the MDS Task Force on Dementia in Parkinson’s Disease

Clinical diagnostic criteria for dementia associated with Parkinson's disease
(Sept 2007)
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz CG, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B
Movement Disorders, 22(12):1689-1707
*A publication of the MDS Task Force on Dementia in Parkinson’s Disease

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations
(Sept 2004)
Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L.
Movement Disorders, 19(9):1020-1028
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease

Parkinson's Disease Non-Motor Symptoms

Clinical rating scales for urinary symptoms in Parkinson disease: Critique and recommendations
(September-October 2018)
Pavy‐Le Traon A, Cotterill N, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Rascol O, Martinez-Martin P, Stebbins GT
Movement Disorders Clinical Practice, 5(5): 479-491
*A publication of the MDS Rating Scales Review Committee

Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease
(July-August 2018)
Dafsari HS, Weiß L, Silverdale M, Rizos A, Reddy P, Ashkan K, Evans J, Reker P, Petry-Schmelzer JN, Samuel M, Visser-Vandewalle V, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L
Brain Stimulation, 11(4): 867-874
*A publication of the MDS Non‐motor Parkinson's Disease Study Group

Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts
(July-August 2018)
Dafsari HS, Petry-Schmelzer JN, Ray-Chaudhuri K, Ashkan K, Weis L, Dembek TA, Samuel M, Rizos A, Silverdale M, Barbe MT, Fink GR, Evans J, Martinez-Martin P, Antonini A, Visser-Vandewalle V, Timmermann L
Brain Stimulation, 11(4): 904-912
*A publication of the MDS Non‐motor Parkinson's Disease Study Group

Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease
(March 2018)
Dafsari HS, Silverdale M, Strack M, Rizos A, Ashkan K, Mahlstedt P, Sachse L, Steffen J, Dembek TA, Visser-Vandewalle V, Evans J, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L
Movement Disorders, 33 (3): 421-430
*A publication of the MDS Non‐motor Parkinson's Disease Study Group 

Global scales for cognitive screening in Parkinson's disease: Critique and recommendations
(Feb 2018)
Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P
Movement Disorders, 33(2):208-218
*A publication of the MDS Rating Scales Review Committee (previously the MDS Committee on Rating Scales Development)

Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age
(January 2018)
Dafsari HS, Reker P, Stalinski L, Silverdale M, Rizos A, Ashkan K, Barbe MT, Fink GR, Evans J, Steffen J, Samuel M, Dembek TA, Visser‐Vandewalle V, Antonini A, Chaudhuri KR, Martinez‐Martin P, Timmermann L
Movement Disorders, 33(1): 99-107
*A publication of the MDS Non‐motor Parkinson's Disease Study Group

Rating scales for pain in Parkinson's disease: Critique and recommendations
(Nov/Dec 2016)
Perez-Lloret S, de Andrade DC, Lyons KE, Rodríguez-Blázquez C, Chaudhuri KR, Deuschl G, Cruccu G, Sampaio C, Goetz CG, Schrag A, Martinez-Martin P, Stebbins GT
Movement Disorders Clinical Practice, 3(6):527-537
*A publication of the MDS Committee on Rating Scales Development

The Movement Disorders task force review of dysautonomia rating scales in Parkinson’s disease with regard to symptoms of orthostatic hypotension
(Sept 2011)
Pavy-Le Traon A, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Shaftman SR, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Stebbins GT, Rascol O
Movement Disorders, 26(11):1985-1992
*A publication of the MDS Task Force on Rating Scales

Scales to assess sleep impairment in Parkinson’s disease: Critique and recommendations
(Dec 2010)
Högl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B, Trenkwalder C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Schrag A, Goetz CG
Movement Disorders, 25(16):2704-2716
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease, and the MDS Sleep Rating Scale Task Force

Fatigue rating scales: Critique and recommendations by the Movement Disorder Society task force on rating scales for Parkinson’s disease
(May 2010)
Friedman JH, Alves G. Hagell P, Marinus J, Marsh L, Martinez-Martin P, Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Schrag A
Movement Disorders, 25(7):805-822
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease

Dysautonomia rating scales in Parkinson’s disease: Sialorrhea, dysphagia, and constipation - Critique and recommendations by Movement Disorders task force on rating scales for Parkinson’s disease
(April 2009)
Evett ML, Chaudhuri KR, Chou KL, Cubo E, Hinson V, Kompoliti K, Yand C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG
Movement Disorders, 24(5):635-646
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease

Apathy and anhedonia rating scales in Parkinson’s disease: Critique and recommendations
(Oct 2008)
Leentjens AFG, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG
Movement Disorders, 23(14):2004-2014
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease

Anxiety rating scales in Parkinson’s disease: Critique and recommendations
(Oct 2008)
Leentjens AFG, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG
Movement Disorders, 23(14):2015-2025
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease

Scales to assess psychosis in Parkinson’s disease: Critiques and recommendations
(Mar 2008)
Fernandez HH, Aarsland D, Fénelon G, Friedman JH, Marsh L, Tröster AI, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG
Movement Disorders, 23(4):484-500
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease

Depression rating scales in Parkinson’s disease: Critique and recommendations
(June 2007)
Schrag A., Barone P, Brown RG, Leentjens AFG, McDonald, WM, Starkstein S, Weintraub D, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG.
Movement Disorders, 22(8):1077-1092
*A publication of the MDS Task Force on Rating Scales for Parkinson’s Disease, and the MDS Depression Rating Scale Task Force

Progressive Supranuclear Palsy

Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
(July 2017)
Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, van Eimeren T, Golbe LI, Kassubek J, Kurz C, Litvan I, Pantelyat A, Rabinovici G, Respondek G, Rominger A, Rowe JB, Stamelou M, Josephs KA
Movement Disorders, 32(7): 955-971
*A publication of the MDS Progressive Supranuclear Palsy Study Group

Which ante-mortem features predict progressive supranuclear palsy?
(July 2017)
Respondek G, Kurz C, Arzberger T, Compta Y, Englund E,  Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner W, Nilsson, C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I, Stamelou M, Höglinger GU
Movement Disorders, 32(7): 995-1005
*A publication of the MDS Progressive Supranuclear Palsy Study Group

Advances in progressive supranuclear palsy: New diagnostic criteria, biomarkers, and therapeutic approaches
(July 2017)
Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU
The Lancet Neurology, 16(7): 552-563
*A publication of the MDS Progressive Supranuclear Palsy Study Group

Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria
(June 2017)
Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol J, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer , Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I
Movement Disorders, 32(6):853-864
*A publication of the Progressive Supranuclear Palsy Study Group

Scales to assess clinical features of progressive supranuclear palsy: MDS Task Force report
(June 2015)
Hall DA, Forjaz MJ, Golbe LI, Litvan I, Payan CAM, Goetz CG, Leentjens AFG, Martinez-Martin P, Pavy Le-Traon A, Sampaio C, Post B, Stebbins G, Weintraub D, Schrag A
Movement Disorders Clinical Practice, 2(2):127-134
*A publication of the MDS Committee on Rating Scales Development and MDS PSP Scales Review Task Force

Rare Movement Disorders

Huntington's disease-like disorders in Latin America and the Caribbean
(August 2018)
Walker RH, Gatto EM, Bustamante ML, Bernal-Pacheco O, Cardoso F, Castilhos RM, Chana P, Cornejo-Olivas M, Bellmann IE, Jardim LB, López-Castellanos R, López-Contreras R, Maia DP, Mazzetti P, Miranda M, Rodríguez-Violante M, Teive H, Tumas V
Parkinsonism & Related Disorders, 53: 10-20
*A publication of the MDS Rare Movement Disorders Study Group

Treatable inherited rare movement disorders
(Jan 2018)
Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia‐Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Munchau A, Kumar P, Oroz MR, Rodríguez-Violante M, Schöls L, Stamelou M, Tijissen M, Roca CU, de la Cerda A, Gatto EM
Movement Disorders, 33(1):21-35
*A publication of the MDS Rare Movement Disorders Study Group

Restless Legs Syndrome

Review of severity rating scales for the Restless Legs Syndrome: Critique and recommendations
(Dec 2014)
Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Schrag A, Stebbins GT
Movement Disorders Clinical Practice, 1(4):317-324
*A publication of the MDS Committee on Rating Scales Development

Review of diagnostic instruments for the Restless Legs Syndrome/Willis-Ekbom disease (RLS/WED): Critique and recommendations
(2014)
Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Stebbins GT, Schrag A
Journal of Clinical Sleep Medicine, 10(12):1343-1349
*A publication of the MDS Committee on Rating Scales Development

Review of quality of life instruments for the Restless Legs Syndrome/Willis-Ekbom disease (RLS/WED): Critique and recommendations 
(2014)
Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Stebbins GT, Schrag A
Journal of Clinical Sleep Medicine, 10(12):1351-1357
*A publication of the MDS Committee on Rating Scales Development (previously the MDS Committee on Rating Scales in Movement Disorders)

Telemedicine

Telemedicine use for movement disorders: A global survey
(December 2018)
Hassan A, Dorsey ER, Goetz CG, Bloem BR, Guttman M, Tanner CM, Mari Z, Pantelyat A, Galifianakis NB, Bajwa JA, Gatto EM, Cubo E
Telemedicine and E-Health, 24(12)
*A publication of the MDS Task Force on Telemedicine

The promise of telemedicine for movement disorders: An interdisciplinary approach
(April 2018)
Ben-Pazi H, Browne P, Chan P, Cubo E, Guttman M, Hassan A, Hatcher-Martin J, Mari Z, Moukheiber E, Okubadejo NU, Shalash A
Current Neurology and Neuroscience Reports, 18(5):26
*A publication of the MDS Task Force on Telemedicine

Telemedicine enables broader access to movement disorders curricula for medical students
(Oct 2017)
Cubo E, Doumbe J, López E, Lopez GA, Gatto E, Persi G, Guttman M
Tremor and Other Hyperkinetic Movements, 2017;7 doi: 10.7916/D8708CXW
*A publication of the MDS Task Force on Telemedicine

The past, present, and future of telemedicine for Parkinson's disease
(June 2014)
Achey M, Aldred JL, Aljehani N, Bloem BR, Biglan KM, Chan P, Cubo E, Dorsey ER, Goetz CG, Guttman M, Hassan A, Khandhar SM, Mari Z, Spindler M, Tanner CM, van den Haak P, Walker R, Wilkinson JR
Movement Disorders, 29(7):871-883
*A publication of the MDS Task Force on Telemedicine

Tics

Systematic review of severity scales and screening instruments for tics: Critique and recommendations
(March 2017)
Martino D, Pringsheim TM, Cavanna AE, Colosimo C, Hartmann A. Leckman JF, Luo S, Munchau A, Goetz CG, Stebbins GT, Martinez-Martin P
Movement Disorders, 32(3):467-473
*A publication of the MDS Committee on Rating Scales Development

Tremor

Consensus Statement on the classification of tremors: From the task force on tremor of the International Parkinson and Movement Disorder Society
(January 2018)
Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, Raethjen J, Stamelou M, Testa CM, Deuschl G
Movement Disorders, 33(1): 75-87
*A publication of the MDS Task Force on Tremor

Proposing a Parkinson's disease-specific tremor scale from the MDS‐UPDRS
(July 2015)
Forjaz MJ, Ayala A, Testa CM, Bain PG, Elble R, Haubenberger D, Rodriguez‐Blazquez C, Deuschl G, Martinez‐Martin P
Movement Disorders, 30(8):1139-1143
*A publication of the MDS Task Force on Tremor

Task force report: Scales for screening and evaluating tremor: Critique and recommendations 
(Nov 2013)
Elble R, Bain P, João Forjaz M, Haubenberger D, Testa C, Goetz CG, Leentjens AF, Martinez-Martin P, Pavy Le-Traon A, Post B, Sampaio C, Stebbins GT, Weintraub D, Schrag A
Movement Disorders, 28(13):1793-1800
*A publication of the MDS Committee on Rating Scales in Movement Disorders

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie notice only applies to movementdisorders.org and mdscongress.org. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice